Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00320931 · ClinicalTrials.gov registry record · NA
Assessment of Coronary Artery Disease by Hybrid PET/CT
A NA study, sponsored by University of Maryland, Baltimore.
- Terminated
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT00320931 is a NA study that was terminated before completion, run by University of Maryland, Baltimore. The registered enrollment target is 30 participants.
The verdict
NCT00320931, a NA study, was terminated before completion, sponsored by University of Maryland, Baltimore.
- TERMINATED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
There have been many advances in the test used to look for heart disease. An example of this newer technology is the Multislice CT scan (MSCT) and Positron Emission Tomography (PET) scans. The use of this type of combined scan may show early coronary artery disease or the degree of damaged heart muscle form a heart attack with a single exam. It may help doctors to know who might benefit from heart surgery or angioplasty to increase the blood flow to the heart. This type of detailed images has previously been available only through cardiac catheterization.
Interventions
- DEVICE Hybrid PET/CT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2006-03 |
| Est. Completion | 2008-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00320931
The ClinicalTrials.gov registry entry for NCT00320931 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hybrid PET/CT is the first listed.
NCT00320931 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00320931 about?
NCT00320931 is a clinical study titled "Assessment of Coronary Artery Disease by Hybrid PET/CT". There have been many advances in the test used to look for heart disease. An example of this newer technology is the Multislice CT scan (MSCT) and Positron Emission Tomography (PET) scans. The use of this type of combined scan may show early coronary artery disease or the degree of damaged heart mu...
What is the current status of trial NCT00320931?
This trial is currently terminated. It is a NA study. The enrollment target is 30 participants. The study started on 2006-03. Estimated completion is 2008-04.
What interventions are being tested in trial NCT00320931?
The interventions under investigation include: Hybrid PET/CT (DEVICE).
Who is sponsoring clinical trial NCT00320931?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.